Oramed Pharm (OJU1) Ownership - Who Owns Oramed Pharm?
Oramed Pharm (OJU1) Ownership Overview
- 25.16% Insiders
- 2.35% Mutual Funds
- 0.71% Other Institutional Investors
- 4.50% ETFs
- 67.29% Public Companies and Individual Investors
The ownership structure of Oramed Pharm (DE:OJU1) stock is a mix of institutional, retail, and individual investors. Approximately 7.55% of the company’s stock is owned by Institutional Investors, 25.16% is owned by Insiders, and 67.29% is owned by Public Companies and Individual Investors.
The ownership structure of Oramed Pharm (DE:OJU1) stock is a mix of institutional, retail, and individual investors. Approximately 7.55% of the company’s stock is owned by Institutional Investors, 25.16% is owned by Insiders, and 67.29% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Nadav Kidron | 4,266,505 | Insider | 10.26% | 17,748,661 |
| Benjamin Shapiro | 2,023,220 | Insider | 4.86% | 8,416,595 |
| BlackRock, Inc. | 1,608,111 | Institution | 3.87% | 6,689,742 |
| Miriam Kidron | 1,550,554 | Insider | 3.73% | 6,450,305 |
| Joshua Hexter | 1,358,130 | Insider | 3.26% | 5,649,821 |
| Ishares | 1,249,205 | Institution | 3.00% | 5,196,693 |
| Gabay Avraham | 881,076 | Insider | 2.12% | 3,665,276 |
| Fidelity Salem Street Trust | 427,225 | Institution | 1.03% | 1,777,256 |
| Vanguard | 239,206 | Institution | 0.58% | 995,097 |
| Vanguard Scottsdale Funds | 229,029 | Institution | 0.55% | 952,761 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Salem Street Trust | 427,225 | Institution | 1.03% | 1,777,256 |
| Vanguard Scottsdale Funds | 229,029 | Institution | 0.55% | 952,761 |
| Schwab Capital Trust | 83,634 | Institution | 0.20% | 347,917 |
| Dfa Investment Dimensions Group Inc | 57,693 | Institution | 0.14% | 240,003 |
| Tiaa-cref Funds | 46,404 | Institution | 0.11% | 193,041 |
| Rbc Funds Trust | 45,300 | Institution | 0.11% | 188,448 |
| Nationwide Mutual Funds | 35,404 | Institution | 0.09% | 147,281 |
| Fidelity Concord Street Trust | 18,879 | Institution | 0.05% | 78,537 |
| Valic Co I | 14,876 | Institution | 0.04% | 61,884 |
| Victory Portfolios Iii | 7,816 | Institution | 0.02% | 32,515 |
FAQ
Who Owns Oramed Pharm (DE:OJU1)?
According to the latest TipRanks data, approximately 7.55% of the company's stock is held by institutional investors, 25.16% is held by insiders, and 67.29% is held by public companies and individual investors.
What percentage of Oramed Pharm (DE:OJU1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.55% of Oramed Pharm (DE:OJU1) stock is held by institutional investors: 2.35% by mutual funds, 4.50% by ETFs and 0.71% by other institutional investors.
What percentage of Oramed Pharm (DE:OJU1) stock is held by retail investors?
According to the latest TipRanks data, approximately 67.29% of Oramed Pharm (DE:OJU1) stock is held by public companies and individual investors.
Who owns the most shares of Oramed Pharm (DE:OJU1)?
Nadav Kidron owns the most shares of Oramed Pharm (DE:OJU1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
